Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0203-2027

CareLink Clinic, REF: MMT-7350 Recall

CareLink Clinic, REF: MMT-7350

FDA recall Class II

Ongoing

FDA lists this Class II recall for CareLink Clinic, REF: MMT-7350. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0203-2027
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Sep 11, 2026
FDA report date
Oct 28, 2026
Quantity in commerce
1
Distribution
See key details
FDA cause
Software design

What is being recalled?

CareLink Clinic, REF: MMT-7350

Affected model & UDI checker

Search the exact identifiers published for Z-0203-2027.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
MMT-7350CareLink Clinic, REF: MMT-7350Check source noticeNot specified
FDA code information

UDI-DI: 0763000B00008748K. Software Versions: 4.4A Software Available: US: Between June 4th, 2026, and June 8th, 2026.

View the original FDA recall notice

Why was this product recalled?

CareLink Clinic software version 4.4A includes a software defect in the Settings Calculator feature in which the calculation logic fails to use custom values entered by healthcare professionals (HCPs) for Total Daily Dose (TDD) or Long-acting insulin when calculating the Carb Ratio, Insulin Sensitivity Factor (ISF), and Max Recommended value for Rapid-acting insulin. Instead, the calculator continues to use the system-recommended values, resulting in incorrect rapid-acting insulin parameters. If an HCP or patient inputs these incorrect setting values into the patient's MiniMed Go app, the patient could deliver higher or lower insulin doses compared to their insulin needs, potentially leading to over/under delivery of insulin with a severity ranging from Catastrophic (death from severe hypoglycemia) to Minor (self-treatable hypoglycemia/hyperglycemia).

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Medtronic MiniMed, Inc. take?

On 9/11/2026, correction notices were mailed to the health care professional, and customer asking them to do the following: The Customer was asked to do the following: Immediately contact your Healthcare Provider (HCP) to confirm your insulin settings values. Complete and return the confirmation form by visiting https://info.medtronicdiabetes.com/FA1587 The health care professional was asked to do the following: If you provided diabetes treatment recommendations to patients based on custom Total Daily Dose(TDD) or long-acting insulin values entered into the CareLin Clinic Settings Calculator between: June 04, 2026, to June 08, 2026, please revisit those recommendations utilizing patients' individual CareLink reports. Continue to follow up with those patients pursuant to your standard of care. If you have further questions or need assistance, please call the firm's 24-Hour Technical Support line at 1-800-646-4633, option 1.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology